Expert proposes changes to accelerated approval reforms in user fee bills

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy